Complaints associated with use of Prefilled Pen B [insulin lispro injection] when used by patients with type 2 diabetes on twice-daily insulin therapy

Trial Profile

Complaints associated with use of Prefilled Pen B [insulin lispro injection] when used by patients with type 2 diabetes on twice-daily insulin therapy

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Aug 2006

At a glance

  • Drugs Insulin lispro (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 03 Aug 2006 Status change
    • 03 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top